Showing 7301-7310 of 8649 results for "".
- Helen Keller Intl and Partners Celebrate Vision Milestone, Screening 1 Million Students in New York Cityhttps://modernod.com/news/helen-keller-intl-and-partners-celebrate-vision-milestone-screening-1-million-students-in-new-york-city/2481208/On October 31, 2022, Helen Keller Intl will reach a major milestone: Its NY Vision team will provide free vision services to its one-millionth New York City student at the Academy for College Preparation and Career Exploration, a community school co-located in the Er
- KYS Vision Reports Clinical Trial Results of Its Remote Physiologic Monitoring System for Patients With Chronic Retinal Conditionshttps://modernod.com/news/kys-vision-reports-clinical-trial-results-of-its-remote-physiologic-monitoring-system-for-patients-with-chronic-retinal-conditions/2481207/KYS Vision announced clinical trial results of its Macustat macular function scan for the remote monitoring of central retinal function. The study was published in the peer-reviewed journal Digital Health1 in October 2022. The study is one
- EyeMed Vision Care Names Matt MacDonald Presidenthttps://modernod.com/news/eyemed-vision-care-names-matt-macdonald-president/2481204/EyeMed has appointed Matt MacDonald to the role of President. Mr. MacDonald succeeds Lukas Ruecker who has decided to step down after 9 years for personal reasons. Mr. MacDonald has been with EyeMed since 2013, and most recently served as Chief Operations Officer. Prior to that, he
- Lumata Health Raises $4 Million in Series A Funding to Scale its Human-Led, Intelligent Eye Care Management Platformhttps://modernod.com/news/lumata-health-raises-4-million-in-series-a-funding-to-scale-its-human-led-intelligent-eye-care-management-platform/2481201/Lumata Health announces $4 million in new venture funding to scale its impact throughout the United States. Lumata Health currently serves thousands of patients suffering from vision-threatening chronic eye conditions through partnerships with ophthalmology clinics and h
- NIH Scientists Discover Essential Step in Recharging the Eye’s Light-Sensing Retinahttps://modernod.com/news/nih-scientists-discover-essential-step-in-recharging-the-eyes-light-sensing-retina/2481200/Scientists have discovered a mechanism by which an area of a protein shape-shifts to convert vitamin A into a form usable by the eye’s light-sensing photoreceptor cells, according to the National Eye Institute. A previously uncharacterized area of the protein known as RPE65 spontaneously tu
- Genentech: Topline Phase 3 Results Show Vabysmo Improved Vision in People With RVOhttps://modernod.com/news/genentech-topline-phase-3-results-show-vabysmo-improved-vision-in-people-with-rvo/2481199/Genentech announced positive topline results from two global phase 3 studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo (faricimab-svoa), in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO).
- Investigational Optejet Microdose Dispenser From Eyenovia Shows Promise in Improving Treatment for Myopia, Presbyopia, and Patients Getting Eye Examshttps://modernod.com/news/investigational-optejet-microdose-dispenser-from-eyenovia-shows-promise-in-improving-treatment-for-myopia-presbyopia-and-patients-getting-eye-exams/2481176/Two recent studies show that the Optejet dispenser from Eyenovia may be a more "human-centric" design than traditional eye droppers, which may make treatments for vision problems, including myopia, presbyopia, and mydriasis easier to deliver, according to Eyenovia.
- LSU Health New Orleans Develops New Human Cell Line to Study Blinding Eye Disordershttps://modernod.com/news/lsu-health-new-orleans-develops-new-human-cell-line-to-study-blinding-eye-disorders/2481175/Under the direction of Boyd Professor Nicolas Bazan, MD, PhD, scientists at LSU Health New Orleans Neuroscience Center of Excellence have developed a new, experimental human cell line from retinal pigment epithelial cells. Called ABC, these cells so closely resemble and retain the properties of n
- Survey Identifies Diabetic Retinopathy Screening and Care as Top Outreach Eye Care Need in Utahhttps://modernod.com/news/survey-identifies-diabetic-retinopathy-screening-and-care-as-top-outreach-eye-care-need-in-utah/2481172/A recent survey of eye care providers and stakeholders identified screening and care for diabetes-related vision loss as the most urgent need for residents on the Navajo Nation, people experiencing homelessness, former refugees, and underinsured or uninsured Utahns, according to a team of health
- Harrow Sells Non-Ophthalmic Compounding Businesshttps://modernod.com/news/harrow-sells-non-ophthalmic-compounding-business/2481162/Harrow announced the sale of its non‑ophthalmic compounding business to Innovation Compounding Pharmacy, LLC, an affiliate of Revelation Pharma Corporation. Financial terms of the deal were not disclosed. Revelation purchased the assets of Harrow’s non‑ophthalmic c